Home » Topics » BioWorld Science

BioWorld Science
RSS

HitGen identifies new NTRK1 inhibitors

Nov. 6, 2019

Ark Biosciences reports topline proof-of-concept data for ziresovir in RSV

Nov. 6, 2019

TNBG-5602 induces lipid accumulation and antiproliferation in liver cancer cells through PPARgamma

Nov. 6, 2019

Incyte patent describes MAP4K1 inhibitors

Nov. 6, 2019

Tempest Therapeutics patents prostanoid EP2 and EP4 receptor antagonists

Nov. 6, 2019

Small molecules clear mutant Huntingtin protein

Nov. 6, 2019

First phase I data presented for influenza vaccine OVX-836

Nov. 6, 2019

Enzyme-replacement gene therapy encoding glucocerebrosidase attenuates PD phenotype

Nov. 6, 2019

EOLO-42016 shows promise in model of inherited ALS

Nov. 6, 2019

Investigators design mouse model of dwarfism with PCSK1 mutation

Nov. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...